tiprankstipranks
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market
CUE
Cue Biopharma
RESEARCH TOOLSreports
Want to see CUE full AI Analyst Report?

Cue Biopharma (CUE) Stock Forecast & Price Target

658 Followers
See the Price Targets and Ratings of:

CUE Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Cue
Biopharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CUE Stock 12 Month Forecast

There Are No Analyst Ratings for CUE In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CUE Financial Forecast

CUE Earnings Forecast

Next quarter’s earnings estimate for CUE is -$1.69 with a range of -$1.69 to -$1.69. The previous quarter’s EPS was -$1.08. CUE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CUE has Performed in-line its overall industry.
Next quarter’s earnings estimate for CUE is -$1.69 with a range of -$1.69 to -$1.69. The previous quarter’s EPS was -$1.08. CUE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CUE has Performed in-line its overall industry.

CUE Sales Forecast

Next quarter’s sales forecast for CUE is $3.00M with a range of $3.00M to $3.00M. The previous quarter’s sales results were $5.69M. CUE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CUE has Performed in-line its overall industry.
Next quarter’s sales forecast for CUE is $3.00M with a range of $3.00M to $3.00M. The previous quarter’s sales results were $5.69M. CUE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CUE has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lucid Capital Analyst forecast on CUE
Dev Prasad
Lucid Capital
Lucid Capital
$4
Buy
1076.47%
Upside
Initiated
08/25/25
Cue Biopharma initiated with a Buy at Lucid CapitalCue Biopharma initiated with a Buy at Lucid Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lucid Capital Analyst forecast on CUE
Dev Prasad
Lucid Capital
Lucid Capital
$4
Buy
1076.47%
Upside
Initiated
08/25/25
Cue Biopharma initiated with a Buy at Lucid CapitalCue Biopharma initiated with a Buy at Lucid Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cue Biopharma

3 Months
Dev PrasadLucid Capital
Success Rate
0/1 ratings generated profit
0%
Average Return
-25.50%
Copying Dev Prasad's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -25.50% per trade.
1 Year
Dev PrasadLucid Capital
Success Rate
0/1 ratings generated profit
0%
Average Return
-18.10%
Copying Dev Prasad's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.10% per trade.
2 Years
Dev PrasadLucid Capital
Success Rate
0/1 ratings generated profit
0%
Average Return
-18.10%
Copying Dev Prasad's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -18.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CUE Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
1
1
1
0
In the current month, CUE has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CUE average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

CUE Stock Forecast FAQ

What is CUE’s average 12-month price target, according to analysts?
Currently, no data Available
What is CUE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CUE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CUE a Buy, Sell or Hold?
      Currently, no data Available
      What is Cue Biopharma Inc’s price target?
      Currently, no data Available
      What do analysts say about Cue Biopharma Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CUE?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.